Showing 1-10 of 2317 results for "".
- Pat Croskerry, MD, PhDhttps://practicaldermatology.com/profiles/pat-croskerry-md-phd/jQYrle/
- Partnershipshttps://practicaldermatology.com/pages/partnerships/Mentorship and Workshops YoungMD Connect YoungMD Connect is a membership-based mentorship and educational platform brought to you by Practical Dermatology and Modern Aesthetics for soon-to-be and newly practicing physicians dedicated to the fields of dermatology and/or aesthetics. YMDC members …
An Inside Look at How Incyte is Addressing Unmet Needs of Patients with Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/an-inside-look-at-how-incyte-is-addressing-unmet-needs-of-patients-with-atopic-dermatitis/20156/Ahmad Naim, Vice President of US Medical Affairs at Incyte, discusses the challenges around atopic dermatitis (AD) management and how Incyte is utilizing its expertise in immunology to address unmet needs for patients.Ensuring Excellent Care Across LGBTQ and Sexual Minority Patients
https://practicaldermatology.com/topics/practice-management/ensuring-excellent-care-across-lgbtq-and-sexual-minority-patients/20077/The session on LGBTQ and sexual gender minority health covered a range of topics including both clinical care as well as terminology, structures, and framework. Klint Peebles, MD talks about the importance of providing excellent dermatologic care as patients face disparities and challenges in accessThe Art of Patient Scheduling
https://practicaldermatology.com/topics/practice-management/the-art-of-patient-scheduling/23676/Is your patient scheduling system working as efficiently as possible? Put these five action items in place to ensure your practice is firing on all cylinders.DermWireTV: Incyte's Opzelura, BMS Patient Week, Science of Skincare Summit
https://practicaldermatology.com/topics/psoriasis/dermwiretv-incytes-opzelura-bms-patient-week-science-of-skincare-summit/20003/Incyte’s Opzelura is the first topical JAK inhibitor approved in the US. Lawrence Eichenfield, MD weighs in on the cream formulation of ruxolitinib for treatment of mild-to-moderate atopic dermatitis in non-immunocompromised patients 12 years of age and older. Bristol Myers Squibb's seventh Global PPRP for Scarring Hair Disorders: Thoughts on Patient Care
https://practicaldermatology.com/topics/hair-nails/prp-for-scarring-hair-disorders-thoughts-on-patient-care/23231/Pearls for supporting patients and implementing PRP in practice.Bespoke for Bros: A Different Approach for Male Patients
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/bespoke-for-bros-a-different-approach-for-male-patients-/19561/Physical features aside, there may be important differences in how male patients think about and approach cosmetic concerns. According to Heidi Waldorf, MD, while women tend to seek a youthful appearance, men often want to appear as though they have not aged—and stopping the aging clock requires a fHow Online Patient Reviews Can Boost the Prospects of Your Dermatology Practice
https://practicaldermatology.com/topics/practice-management/how-online-patient-reviews-can-boost-the-prospects-of-your-dermatology-practice/20816/Build your brand by asking for positive online reviews from the right patients at the right time.Improving Patient Interactions
https://practicaldermatology.com/topics/practice-management/improving-patient-interactions/18805/From treating hospitalized patients, to delivering bad news, to helping patients manage chronic conditions, and even dealing with difficult patients, this episode of Derm Insider focuses on improving patient care and the doctor/patient relationship. Joanna L. Harp, MD, Kanade Shinkai, MD, PhD, Krist
- Prev
- Next